Trials of an AI technology designed to detect prostate cancer have begun at three hospitals in the United Kingdom.
The artificial intelligence technology, named “Prostate Suite,” is being tested as part of the “ARTICULATE PRO” study.
It is worth noting that the AI system is designed to help doctors detect, classify, and measure tumors in prostate biopsies and tissue samples.
Hospitals participating actively in the trials include North Bristol Trust Southmead Hospital, University Hospitals Coventry and Warwickshire, and Oxford University NHS Foundation Trust.
